Estimating the Number of Droplets and Drug Particles Emitted from MDIs
- Stephen W. Stein
- … show all 1 hide
The objective of this paper is to assess the number of drug particles or droplets contained in metered dose inhaler (MDI) aerosols. Equations were developed to estimate this. The number of drug particles was estimated to be as high as about 300 million for QVAR® solution MDIs and as low as 670,000 for Beclovent™ MDIs. The number of particles in MDI aerosols was shown to be highly dependent on the mass median aerodynamic diameter (MMAD) and geometric standard deviation, and to a lesser extent the total mass of the aerosol. It was demonstrated that when the number of particles are calculated assuming that the aerosol is monodisperse and using the MMAD as the particle size, the number of particles are significantly underestimated. The number of droplets atomized from HFA-134a MDIs was estimated to range from about 220 million to about 1.1 billion droplets per actuation. For solution MDIs, each of the atomized droplets contains drug and thus the number of drug particles is the same as the number of atomized droplets. However, for suspension MDI formulations many of the droplets do not contain any micronized drug particles and the number of drug particles is much lower than the number of atomized droplets.
- B. J. Meakin, D. A. Lewis, D. Ganderton, and G. Brambilla. Countering challenges posed by mimicry of CFC performance using HFA systems. In R. N. Dalby, P. R. Byron, S. J. Farr, and J. Peart (eds.), Respiratory Drug Delivery-VII, Serentec, Raleigh, pp. 99–107 (2000).
- S. W. Stein and P. B. Myrdal. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. J. Pharm. Sci. 93:2158–2175 (2004). CrossRef
- I. Gonda. Development of a systematic theory of suspension inhalation aerosols-I. A framework to study the effects of aggregation on the aerodynamic behaviour of drug particles. Int. J. Pharm. 27:99–116 (1985). CrossRef
- P. H. Howarth. Why particle size should affect clinical response to inhaled therapy. J. Aerosol. Med. 14:S27–S34 (2001). CrossRef
- L. Harrison, C. Leach, J. Machacek, J. Vanden Burgt, and J. Vogel. Beneficial effects with reduced particle size and CFC-free extrafine aerosol steroid on lung deposition, absorption, efficacy and safety. Am. J. Respir. Crit. Care. Med. 155:A666 (1997).
- A. J. Hickey, T. B. Martonen, Y. Yang. Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols. Pharmaceutica Acta Helvetiae. 71:185–190 (1996). CrossRef
- C. A. Malton, G. W. Hallworth, J. M. Padfield. The association and particle size distribution of drug and surfactant discharged from a metered-dose inhalation aerosol. J. Pharm. Pharmacol. 34:65P (1982).
- L. McKenzie, and M. J. Oliver. Evaluation of the particle formation process after actuation of solution MDIs. J Aerosol. Med. 13:59 (2000). CrossRef
- T. Hatch, and S. P. Choate. Statistical description of the size properties of non-uniform particulate substances. J. Franklin Inst. 207:369 (1929). CrossRef
- W. C. HindsAerosol technology: properties, behavior, and measurement of airborne particles, Wiley, New York, pp. 91–95 (1982).
- S. W. Stein. Size distribution measurements of metered dose inhalers using Andersen Mark II cascade impactors. Int. J. Pharm. 186:43–52 (1999). CrossRef
- J. P. Mitchell, M. W. Nagel, K. J. Wiersema, C. C. Doyle. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometerAAPS PharmSciTech [http://www.aapspharmscitech.org] 4(4):54 (2003).
- USP 26-NF 21. Chapter 601-Physical tests and determinations: aerosols. United States Pharmacopeia. Rockville: United States Pharmacopeial Convention. 2105–2123 (2003).
- S. W. Stein, B. J. Gabrio, and T. J. Beck. Evaluation of a new aerodynamic particle sizer spectrometer for MDI size distribution measurements. In R. N. Dalby, P. R. Byron, S. J. Farr, and J. Peart (eds.), Respiratory Drug Delivery-VII, Serentec, Raleigh, pp. 283–286 (2000).
- Estimating the Number of Droplets and Drug Particles Emitted from MDIs
Volume 9, Issue 1 , pp 112-115
- Cover Date
- Online ISSN
- Springer US
- Additional Links
- metered dose inhaler
- number of particles
- size distribution
- Industry Sectors
- Stephen W. Stein (1)
- Author Affiliations
- 1. Early Pharmaceutics and Technology Department, 3M Drug Delivery Systems, 3M Center—Building 260–3A-05, St. Paul, Minnesota, USA